Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Review of the TAIFUN multidose dry powder inhaler technology.

Overhoff KA, Clayborough R, Crowley M.

Drug Dev Ind Pharm. 2008 Sep;34(9):960-5. doi: 10.1080/03639040802154897 . Review.

PMID:
18686086
2.

Nebulization of nanoparticulate amorphous or crystalline tacrolimus--single-dose pharmacokinetics study in mice.

Sinswat P, Overhoff KA, McConville JT, Johnston KP, Williams RO 3rd.

Eur J Pharm Biopharm. 2008 Aug;69(3):1057-66. doi: 10.1016/j.ejpb.2008.01.037. Epub 2008 Feb 16.

PMID:
18406587
3.

Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing.

Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO 3rd.

Pharm Res. 2008 Jan;25(1):167-75. Epub 2007 Oct 30.

PMID:
17968635
4.

Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.

Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO 3rd.

Int J Pharm. 2007 May 4;336(1):122-32. Epub 2006 Nov 26.

PMID:
17184938
5.

Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.

Overhoff KA, Engstrom JD, Chen B, Scherzer BD, Milner TE, Johnston KP, Williams RO 3rd.

Eur J Pharm Biopharm. 2007 Jan;65(1):57-67. Epub 2006 Jul 26.

PMID:
16987642
6.

Cryogenic liquids, nanoparticles, and microencapsulation.

Purvis T, Vaughn JM, Rogers TL, Chen X, Overhoff KA, Sinswat P, Hu J, McConville JT, Johnston KP, Williams RO 3rd.

Int J Pharm. 2006 Oct 31;324(1):43-50. Epub 2006 Apr 28.

PMID:
16814968
7.

Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.

McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS, Talbert RL, Peters JI, Johnston KP, Williams RO 3rd.

Pharm Res. 2006 May;23(5):901-11. Epub 2006 May 5.

PMID:
16715380
8.

In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.

Hoeben BJ, Burgess DS, McConville JT, Najvar LK, Talbert RL, Peters JI, Wiederhold NP, Frei BL, Graybill JR, Bocanegra R, Overhoff KA, Sinswat P, Johnston KP, Williams RO 3rd.

Antimicrob Agents Chemother. 2006 Apr;50(4):1552-4.

9.

Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process.

Rogers TL, Overhoff KA, Shah P, Santiago P, Yacaman MJ, Johnston KP, Williams RO 3rd.

Eur J Pharm Biopharm. 2003 Mar;55(2):161-72.

PMID:
12637092

Supplemental Content

Loading ...
Support Center